How to Read Your Semaglutide Lab Results

You started semaglutide, you’re losing weight, and now your provider has ordered bloodwork. The results come back and you’re staring at a column of numbers, abbreviations, and reference ranges without a clear sense of what any of it means for your treatment. This guide breaks down the key lab markers relevant to semaglutide therapy, what direction you want them moving, and what findings should prompt a conversation with your provider.

Why Lab Monitoring Matters on Semaglutide

Semaglutide affects multiple metabolic systems simultaneously. It changes how your body handles blood sugar, influences kidney function, alters lipid metabolism, and drives significant weight loss that has its own downstream effects on organ function. Monitoring labs isn’t just a formality. It’s how your provider tracks whether the medication is doing what it’s supposed to do and catches anything unexpected early.

The specific tests ordered will vary depending on your health history, whether you have diabetes, and how long you’ve been on treatment. But there’s a core set of markers that appear on most semaglutide monitoring panels, and understanding what each one reflects helps you have more informed conversations with your care team. For a broader overview of what testing to expect throughout treatment, What Lab Tests to Expect While on GLP-1 Medications covers the full picture.

Blood Sugar Markers

Fasting Glucose

Fasting glucose measures the concentration of sugar in your blood after an overnight fast. The normal range is typically 70–99 mg/dL. Values between 100–125 mg/dL indicate prediabetes, and 126 mg/dL or higher on two separate tests indicates diabetes.

On semaglutide, fasting glucose generally decreases over time, sometimes substantially. If your fasting glucose was in the prediabetes range before starting, moving into the normal range after several months of treatment is a meaningful clinical win. If you’re diabetic, watch for values dropping below 70 mg/dL, which indicates hypoglycemia and warrants a medication review.

HbA1c (Glycated Hemoglobin)

HbA1c reflects your average blood sugar over the past two to three months. Normal is below 5.7%, prediabetes is 5.7–6.4%, and diabetes is 6.5% and above.

Semaglutide reliably lowers HbA1c in both diabetic and prediabetic patients. In clinical trials, reductions of 1–2 percentage points are common, and some patients see even larger drops. If your HbA1c isn’t moving after three to six months on a therapeutic dose, that’s worth discussing with your provider, as it may indicate a need for dose adjustment or additional interventions. How Ozempic Affects Your A1C walks through the expected timeline in detail.

Lipid Panel

LDL Cholesterol

LDL, often called “bad” cholesterol, is a primary driver of cardiovascular risk when elevated. Optimal LDL is generally below 100 mg/dL for most people, and below 70 mg/dL for those with established heart disease.

Semaglutide tends to modestly reduce LDL over time, particularly as body weight decreases. A downward trend in your LDL across consecutive lab draws is a positive sign. If LDL remains elevated despite weight loss and medication, your provider may consider additional interventions.

HDL Cholesterol

HDL is the “good” cholesterol that helps remove LDL from the bloodstream. Higher is better. Optimal HDL is generally above 60 mg/dL for both men and women, with values below 40 mg/dL (men) or 50 mg/dL (women) considered a risk factor.

HDL tends to increase modestly with weight loss on semaglutide. Even small improvements here contribute to a better overall cardiovascular risk profile.

Triglycerides

Triglycerides are blood fats that rise with excess carbohydrate intake, alcohol consumption, obesity, and insulin resistance. Normal is below 150 mg/dL. Elevated triglycerides, particularly above 500 mg/dL, carry their own risks including pancreatitis.

Semaglutide often produces significant triglyceride reductions, sometimes more dramatic than the LDL changes. If you came in with elevated triglycerides, watching this number drop over the first six months of treatment is one of the more gratifying trends in the labs. High Triglycerides and GLP-1 Medications covers what drives these improvements.

Kidney Function

Creatinine and eGFR

Creatinine is a waste product filtered by the kidneys. Elevated creatinine suggests the kidneys aren’t filtering efficiently. eGFR (estimated glomerular filtration rate) is calculated from creatinine and provides a direct estimate of kidney function. Normal eGFR is above 60 mL/min/1.73m², with values below 30 indicating significant impairment.

Here’s why this matters on semaglutide: the medication is cleared partly through the kidneys, and patients with impaired kidney function may need dose adjustments or closer monitoring. Interestingly, research suggests semaglutide may have protective effects on kidney function over time, particularly in people with diabetes-related kidney disease. A stable or improving eGFR during treatment is a good sign.

BUN (Blood Urea Nitrogen)

BUN is another kidney marker that reflects protein metabolism. It’s often evaluated alongside creatinine. Mildly elevated BUN can sometimes occur with rapid weight loss due to increased protein breakdown, so your provider will interpret this in the context of your overall results rather than in isolation.

Liver Enzymes

ALT and AST

ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are enzymes that indicate liver cell health. Elevated levels suggest liver stress or damage. Normal ALT is roughly 7–56 U/L and normal AST is roughly 10–40 U/L, though reference ranges vary slightly by lab.

Many patients starting semaglutide have mildly elevated liver enzymes due to fatty liver disease associated with obesity or metabolic syndrome. As weight loss progresses, ALT and AST often normalize, which reflects actual improvement in liver health. Semaglutide’s effects on fatty liver disease are an active area of research. Tirzepatide and Fatty Liver Disease covers related evidence if you’re on tirzepatide instead.

A meaningful rise in liver enzymes during treatment, rather than a decrease, warrants prompt attention and is not an expected effect of semaglutide.

Pancreatic Markers

Lipase and Amylase

These enzymes are produced by the pancreas. Significantly elevated lipase or amylase can indicate pancreatitis, which is a rare but serious potential complication associated with GLP-1 medications.

Most providers don’t routinely check lipase and amylase at every visit unless a patient has a history of pancreatitis or gallbladder disease, or reports symptoms like severe upper abdominal pain radiating to the back. If you experience those symptoms, seek evaluation promptly rather than waiting for a scheduled lab draw.

Thyroid Function

TSH (Thyroid Stimulating Hormone)

TSH is the primary screening test for thyroid function. Normal range is approximately 0.4–4.0 mIU/L. GLP-1 medications carry a theoretical concern about thyroid C-cell tumors based on animal studies, though this has not been demonstrated in human clinical trials at the doses used therapeutically.

Patients with pre-existing thyroid conditions are often monitored more closely. If you have hypothyroidism and are on thyroid medication, weight loss on semaglutide can sometimes affect how much thyroid hormone your body needs, making TSH monitoring particularly relevant. Thyroid Issues and Ozempic covers the interaction in more detail.

Reading Your Results in Context

Individual lab values matter less than trends over time. A single slightly-out-of-range result is rarely cause for alarm. What your provider is looking for is the direction your markers are moving across multiple draws, whether the metabolic improvements associated with weight loss are showing up in the numbers, and whether any unexpected findings require attention.

If you’re tracking your own progress alongside your labs, How to Track Your Progress on Semaglutide or Tirzepatide offers a framework that goes beyond the scale.

If you haven’t started semaglutide yet and want to understand what the process looks like from consultation through ongoing monitoring, start your assessment at TrimRx to connect with a clinician who can guide your treatment from day one.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.